Both in Pharmaceuticals
Bicara Therapeutics vs LB Pharmaceuticals
Over the past year BCAX returned +17.9% and LBRX returned +143.1%; their daily moves had a correlation of 0.24.
BCAX +17.9% LBRX +143.1%Growth of $1, one year, split-adjusted
| Metric | BCAX | LBRX |
|---|---|---|
| Price | $18.61 | $38.38 |
| Market cap | $1.23B | $1.24B |
| Today | +0.27% | +2.95% |
| 1 month | −19.5% | −18.8% |
| 6 months | −6.4% | +55.6% |
| Year to date | +10.6% | +72.4% |
| 1 year | +34.2% | +151.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $497.3M | $327.8M |
| Dividend yield | — | — |
| Volatility (60d) | 55.7% | 58.2% |
| Short % of float | 22.1% | 23.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).